306 related articles for article (PubMed ID: 23604116)
1. Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins.
Reyes D; Ballaré C; Castellano G; Soronellas D; Bagó JR; Blanco J; Beato M
Oncogene; 2014 Mar; 33(12):1570-80. PubMed ID: 23604116
[TBL] [Abstract][Full Text] [Related]
2. Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3.
Vicent GP; Ballaré C; Nacht AS; Clausell J; Subtil-Rodríguez A; Quiles I; Jordan A; Beato M
Mol Cell; 2006 Nov; 24(3):367-81. PubMed ID: 17081988
[TBL] [Abstract][Full Text] [Related]
3. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
4. Chromatin remodeling and control of cell proliferation by progestins via cross talk of progesterone receptor with the estrogen receptors and kinase signaling pathways.
Vicent GP; Ballaré C; Zaurin R; Saragüeta P; Beato M
Ann N Y Acad Sci; 2006 Nov; 1089():59-72. PubMed ID: 17261755
[TBL] [Abstract][Full Text] [Related]
5. Mitogen- and stress-activated protein kinase 1 MSK1 regulates glucocorticoid response element promoter activity in a glucocorticoid concentration-dependent manner.
Beck IM; Clarisse D; Bougarne N; Okret S; Haegeman G; De Bosscher K
Eur J Pharmacol; 2013 Sep; 715(1-3):1-9. PubMed ID: 23831393
[TBL] [Abstract][Full Text] [Related]
6. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
Carnevale RP; Proietti CJ; Salatino M; Urtreger A; Peluffo G; Edwards DP; Boonyaratanakornkit V; Charreau EH; Bal de Kier Joffé E; Schillaci R; Elizalde PV
Mol Endocrinol; 2007 Jun; 21(6):1335-58. PubMed ID: 17440047
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of transcription factor promoter regions by low-dose genistein through mitogen-activated protein kinase and mitogen-and-stress activated kinase 1 nongenomic signaling.
Yu L; Ham K; Gao X; Castro L; Yan Y; Kissling GE; Tucker CJ; Flagler N; Dong R; Archer TK; Dixon D
Cell Commun Signal; 2016 Aug; 14(1):18. PubMed ID: 27582276
[TBL] [Abstract][Full Text] [Related]
8. Chromatin modification of the trefoil factor 1 gene in human breast cancer cells by the Ras/mitogen-activated protein kinase pathway.
Espino PS; Li L; He S; Yu J; Davie JR
Cancer Res; 2006 May; 66(9):4610-6. PubMed ID: 16651411
[TBL] [Abstract][Full Text] [Related]
9. Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation.
Kim HG; Lee KW; Cho YY; Kang NJ; Oh SM; Bode AM; Dong Z
Cancer Res; 2008 Apr; 68(7):2538-47. PubMed ID: 18381464
[TBL] [Abstract][Full Text] [Related]
10. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases.
Skildum A; Faivre E; Lange CA
Mol Endocrinol; 2005 Feb; 19(2):327-39. PubMed ID: 15486045
[TBL] [Abstract][Full Text] [Related]
11. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
Chen FP; Chien MH; Chen HY; Huang TS; Ng YT
Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375
[TBL] [Abstract][Full Text] [Related]
12. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor.
Migliaccio A; Piccolo D; Castoria G; Di Domenico M; Bilancio A; Lombardi M; Gong W; Beato M; Auricchio F
EMBO J; 1998 Apr; 17(7):2008-18. PubMed ID: 9524123
[TBL] [Abstract][Full Text] [Related]
13. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
[TBL] [Abstract][Full Text] [Related]
14. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
Faivre E; Skildum A; Pierson-Mullany L; Lange CA
Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
[TBL] [Abstract][Full Text] [Related]
15. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ
Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686
[TBL] [Abstract][Full Text] [Related]
16. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.
McGowan EM; Russell AJ; Boonyaratanakornkit V; Saunders DN; Lehrbach GM; Sergio CM; Musgrove EA; Edwards DP; Sutherland RL
Cancer Res; 2007 Sep; 67(18):8942-51. PubMed ID: 17875737
[TBL] [Abstract][Full Text] [Related]
17. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
[TBL] [Abstract][Full Text] [Related]
18. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B
Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
[TBL] [Abstract][Full Text] [Related]
19. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
[TBL] [Abstract][Full Text] [Related]
20. Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines.
Read LD; Keith D; Slamon DJ; Katzenellenbogen BS
Cancer Res; 1990 Jul; 50(13):3947-51. PubMed ID: 1972345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]